China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S
03320: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$7.60 | Wtzvbqs | Jrdtqhpb |
CR Pharma Is a Chinese Pharmaceutical Conglomerate Facing Uncertain Times
Business Strategy and Outlook
China Resources Pharmaceutical Group, or CR Pharma, is a healthcare conglomerate that operates manufacturing, distribution, and retail pharmacy segments. Chinese healthcare industries have grown faster than GDP, and will continue to do so due to aging demographics, increased urbanization, a larger middle class, and rising disease rates.